Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study - Test2 - elhamkhani - TriplyDB

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

http://www.wikidata.org/entity/Q28138182

about

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Dementia / Alzheimer's Disease.Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.Nonsteroidal anti-inflammatory drugs, aspirin, and cognitive function in the Baltimore longitudinal study of aging The association between cognition and histamine-2 receptor antagonists in African Americans.The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset Targeting the endocannabinoid system in Alzheimer's disease.Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.Axon growth inhibition by RhoA/ROCK in the central nervous system.Alzheimer disease therapeutics.Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?Thinking preventively about dementia: a review.Histamine-2 receptor antagonist use and incident dementia in an older cohort Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain.A blood-based algorithm for the detection of Alzheimer's disease Decreased C-reactive protein levels in Alzheimer disease Intracranial volume and dementia: some evidence in support of the cerebral reserve hypothesis.Future directions in the treatment of Alzheimer's disease.Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.Inflammatory processes and Alzheimer's disease.Fatty acid oxidation in the pathogenesis of Alzheimer's disease.Rho kinase, a promising drug target for neurological disorders.Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons.Young microglia restore amyloid plaque clearance of aged microglia.Histamine Induces Alzheimer's Disease-Like Blood Brain Barrier Breach and Local Cellular Responses in Mouse Brain Organotypic Cultures.Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women.Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease.Dementia and its implications for public health.Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.Pharmacotherapy of Alzheimer disease.Novel strategies for Alzheimer's disease treatment.Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer's Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan.

P2860

Q24203739-2027A2FC-D870-4D6C-8271-74C7274A3551 Q24681261-CCB3989A-6F85-4F00-AA38-440D452A431D Q24792960-E535AA28-269E-4540-B97A-E7C8BDE53BC5 Q24803797-A5A622C2-A572-4671-9BF0-5598E55DB601 Q25257388-A8BAEB13-7098-409E-83D2-2E531D02E24B Q30668465-523BA8C6-512A-45D9-9DD1-88D49B583F5D Q33206399-2FFADD13-1A3A-42B6-9BFE-1E3256CDA626 Q33265122-703B1060-F9F5-4646-AAF1-FCD618FFC569 Q33359453-30F76795-EC65-4B23-8C31-9018886C8D9C Q33588687-B8903A4C-8168-4532-92B8-4C3DFCA7FD11 Q33706542-6D5BDD51-5465-4EB3-B213-BBBAB4534BE6 Q33814382-1A2AB99E-AF33-4148-8DEA-FB4F822FBF05 Q33873941-24C1597D-B2AC-419D-8BAA-906340FBC9DF Q33930000-5EE2F026-CD95-4903-9F24-50C6CBA6E760 Q34144290-ED1C9B7E-42F5-4B92-AED8-300A59329E87 Q34384966-4FAB833C-ABF3-4E42-9839-4B987A0EA35D Q34393812-299BDAFE-B644-4A06-8D8B-1367FA1283FA Q34608998-09CA72A6-D7AB-4532-AE27-0B91E7848367 Q34906613-C1B74FCA-2A4F-4C43-AEF0-9BCE13A4616D Q35047417-4E345247-8FDA-42FA-BD16-BE0B194BCD3F Q35060487-FD2F07D2-E10D-445B-8553-CE1B8572475D Q35203409-C7533086-A7DB-40CF-AB63-2A638C675B8B Q35482118-633596BF-08D5-410F-AA9D-1E1A51F4335A Q35697954-17B293FF-5924-4BF3-A301-288DE0AFCB4D Q35753450-E6D07DB5-E0C9-438B-A2AB-913CE26A0E60 Q35806684-7B2F9817-D579-43D9-B365-B768E295BED7 Q36106855-FF3A9138-8FC8-4F0A-9E41-AAFD45648396 Q36108432-16A7A86B-6C6F-4273-AC81-DDAA95F06189 Q36111908-EEF1008E-44A4-4C4B-A62F-9B9DAE22AD5E Q36136995-A2882E0C-6E60-4F30-BF5E-D0CE1E9E5742 Q36231976-534F51D4-73DC-4975-96C6-4D56B0DA8D50 Q36366819-BF82D211-0692-43B9-9A49-9A8DC99217F7 Q36370466-D5DF5AFE-1D15-47AF-ABEA-3A5F4BD04C0D Q36402221-7638F817-C6C7-4019-A06F-9C5C72FECF5B Q36422185-C5881421-8EEF-45B7-ACC8-513A72C0DF39 Q36817040-4509F1CA-3A1C-442F-B118-48E5D4AE6C61 Q36818193-CF2F6E12-D467-4E6D-9EDA-7202E8FF836B Q37004359-051A6E89-CE84-48F2-8829-DA443E4F014B Q37012066-BA52D580-A193-4C53-ADF9-BCE30A457B5E Q37404793-735E3A92-13D0-4952-96A9-E93A4BC224DA

P2860

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

http://www.wikidata.org/entity/Q28138182

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Reduced prevalence of AD in us ...... onists: the Cache County study

@ast

Reduced prevalence of AD in us ...... onists: the Cache County study

@en

Reduced prevalence of AD in us ...... onists: the Cache County study

@nl

type

label

Reduced prevalence of AD in us ...... onists: the Cache County study

@ast

Reduced prevalence of AD in us ...... onists: the Cache County study

@en

Reduced prevalence of AD in us ...... onists: the Cache County study

@nl

prefLabel

Reduced prevalence of AD in us ...... onists: the Cache County study

@ast

Reduced prevalence of AD in us ...... onists: the Cache County study

@en

Reduced prevalence of AD in us ...... onists: the Cache County study

@nl

P1433

Q28138182-65A95104-B25A-4250-9C30-F3413A7D198C

P1476

Q28138182-D35DF762-6E66-4F4C-B0BB-40E3C5784BC8

P2093

Q28138182-294F0A19-F18D-4ADD-9B59-13EE1868E777

Q28138182-554FE18A-7E4A-4EC6-A7D9-1B02BB7F794F

Q28138182-5CC3FF57-5E9E-4973-A28C-B0F41FA439AE

Q28138182-818124D6-6A5C-411A-97E7-1109231C0249

Q28138182-861D0030-7708-4F7B-B4C4-D5DD0CA762AD

Q28138182-AA6D99F4-A310-404D-BEB6-E598C98B56AA

Q28138182-E7E21759-967A-438C-A331-CD0A559F5EDF

P304

Q28138182-AE38BE66-8CF1-4F9A-A946-4DCAE2F1D53E

P31

Q28138182-F4B4D8ED-A9F9-4DC1-B3D6-0DCD743D6123

P3181

Q28138182-BF1781C4-BC89-46FC-BB06-A870ED014F34

P356

Q28138182-73BB5B2B-4045-4C20-8D71-008A724CCAA1

P407

Q28138182-7CE4AE4D-F9BA-4C0B-B364-4749270E2F93

P433

Q28138182-5BF94721-72FD-4DFC-94C4-C574897E16CC

P478

Q28138182-AC6ECB20-7134-4A39-B797-0C1DFB976479

P577

Q28138182-8CB2C41A-5801-47F8-81FC-ACD1AB7F98D7

P698

Q28138182-9524CA1F-11AA-4B37-BFF5-32102D65D5C3

P3181

P356

P1433

P1476

Reduced prevalence of AD in us ...... onists: the Cache County study

@en

P2093

I Jurasova

http://www.w3.org/2001/XMLSchema#string

J C Anthony

http://www.w3.org/2001/XMLSchema#string

J C Breitner

http://www.w3.org/2001/XMLSchema#string

M C Norton

http://www.w3.org/2001/XMLSchema#string

M R Meyer

http://www.w3.org/2001/XMLSchema#string

P P Zandi

http://www.w3.org/2001/XMLSchema#string

S V Stone

http://www.w3.org/2001/XMLSchema#string

P304

2066-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2763466

http://www.w3.org/2001/XMLSchema#string

P356

10.1212/WNL.54.11.2066

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10851364

http://www.w3.org/2001/XMLSchema#string